Together with our colleagues from the NASCOLA organisation in North-America we have performed an evaluation of the results of the ECAT external quality assessment programme for Heparin-Induced Thrombocytopenia (HIT) for the period 2013 – 2017 .
Abstract
Background: Accurate diagnosis of heparin‐induced thrombocytopenia (HIT) is essential to ensure timely treatment and prevent complications. Current diagnostic assays include enzyme‐linked immunosorbent assays (ELISAs) and rapid immunoassays (RIs). RIs offer fast turnaround times but were not significantly represented in previous external proficiency testing challenges.
Objectives: To use external proficiency testing to assess qualitative concordance for heparin/PF4 antibody detection.
Methods: From 2013 to 2017, the External Quality Control for Assays and Tests (ECAT) Foundation distributed 10 samples internationally.
Results: In total, 437 laboratories submitted 3149 results. ELISAs accounted for 1484 (47%) responses with RIs accounting for 1665 (53%) responses. RI use increased over the 5‐year period. ELISAs classified 96% of both consensus positive and consensus negative samples concordantly. The coefficient of variation (CV) for positive sample optical densities (ODs) ranged from 35% to 50% when combining ELISA assay methods together. Quantitative RIs classified 97% of consensus‐positive and 98% of consensus‐negative samples concordantly. Qualitative RIs had a higher proportion of discordant responses and classified 88% of consensus‐positive samples and 73% of consensus‐negative samples concordantly. Of RIs only latex immunoassays and IgG specific chemiluminescent assays identified > 95% of samples concordantly with consensus.
Conclusion: Quantitative RIs and ELISAs classify > 95% of samples concordantly. The ODs from different ELISA methods vary considerably and are not interchangeable. Qualitative RI use is increasing despite a greater proportion of discordant classifications. This includes a higher than expected number of negative classifications for consensus‐positive samples among many RIs, challenging their use as “rule out” tests.
J Thromb Haemost 2019 Vol. 17 Issue 12 Pages 2123-2130
This is publication can be approached via the following link: https://www.jthjournal.org/article/S1538-7836(22)03091-4/fulltext